Trump Announces Deals With Eli Lilly, Novo Nordisk To Lower Obesity Drug Prices
Synopsis
At a White House event, the U.S. President noted that it’s a triumph for American patients, which will save lives and improve the health of millions of Americans.
President Donald Trump on Thursday announced deals with obesity drug makers Eli Lilly and Novo Nordisk to cut prices on their GLP-1 drugs in return for a three-year U.S. tariff reprieve.
“It’s a triumph for American patients that will save lives and improve the health of millions and millions of Americans,” Trump said at a White House event.
Get updates to this developing story directly on Stocktwits.<
Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.